Astrana Health, INC Form 4 insider transactions

Astrana Health, Inc. Director Matthew Mazdyasni was granted 6,449 shares of restricted common stock, aligning his interests with shareholders.

Astrana Health, Inc. Director Linda Marsh was granted 6,449 shares of common stock as restricted stock, vesting by June 2026 or the 2026 annual meeting.

Astrana Health, Inc. Director Mitchell W. Kitayama was granted 6,449 shares of common stock under the company's 2024 Equity Incentive Plan, increasing his total beneficial ownership to 21,060 shares.

Astrana Health, Inc. Director Weili Dai was granted 6,449 shares of common stock as restricted stock, aligning her interests with shareholders.

Astrana Health, Inc. Director John Chiang was granted 6,449 shares of common stock as part of the company's 2024 Equity Incentive Plan, aligning his interests with shareholders.

Astrana Health, Inc. Director David Schmidt was granted 6,449 shares of restricted common stock on June 11, 2025, as part of the company's 2024 Equity Incentive Plan.

Astrana Health, Inc.'s Chief Medical Officer, Dinesh M. Kumar, reported a disposition of 1,656 shares of common stock to cover tax withholding obligations, while retaining substantial beneficial ownership.

Chandan Basho, COO and CFO of Astrana Health, surrendered 10,035 shares of common stock to cover tax obligations related to vested restricted stock.

Dinesh M. Kumar, Chief Medical Officer of Astrana Health, sold shares to cover tax obligations related to vesting restricted stock.

Chandan Basho, COO and CFO of Astrana Health, Inc., reported surrendering 2,683 shares of common stock to cover tax obligations related to vested restricted stock.

Chandan Basho, COO and CFO of Astrana Health, surrendered 1,394 shares to cover tax obligations related to vested restricted stock units.

Glenn Sobotka, Chief Accounting Officer of Astrana Health, Inc., reports the acquisition of restricted stock and performance-based restricted stock.

Astrana Health's CEO, Brandon Sim, reported the acquisition and disposal of company stock, including restricted stock units and shares surrendered for tax obligations.

Chandan Basho, COO and CFO of Astrana Health, Inc., reports the acquisition of 26,701 shares of common stock through a restricted stock unit grant.

Director Thomas S. Lam of Astrana Health, Inc. sold shares to cover tax withholding obligations related to vesting restricted stock.

Dinesh Kumar, Chief Medical Officer of Astrana Health, reports acquisition of restricted stock units and disposition of shares to cover tax obligations.

Kenneth T. Sim, Executive Chairman of Astrana Health, reports changes in beneficial ownership of common stock due to a pro rata distribution by Allied Physicians of California.

Allied Physicians of California, a significant shareholder of Astrana Health, distributed shares of Astrana Health common stock to its stockholders via a pro rata distribution.

Thomas Lam, a director at Astrana Health, reported a pro rata stock distribution from Allied Physicians of California and vesting of restricted stock.

Dinesh M. Kumar, Chief Medical Officer of Astrana Health, sold 7,210 shares of common stock to cover tax obligations related to vesting restricted stock.

Astrana Health repurchased 300,000 shares of its common stock from Allied Physicians of California on January 17, 2025, at a price of $35.17 per share.

Astrana Health's Chief Medical Officer, Dinesh M. Kumar, sold 967 shares of common stock to cover tax obligations related to vesting restricted stock.

Astrana Health, Inc. repurchased 5,100 shares of its common stock, including restricted stock, on December 10, 2024.

Astrana Health's Chief Accounting Officer, John Vong, surrendered 134 shares to cover tax obligations related to vesting restricted stock.

Astrana Health director Mitchell Kitayama exercised stock options and disposed of shares, resulting in a change in his beneficial ownership.

Director John Chiang exercised stock options and disposed of shares of Astrana Health, Inc. on November 19, 2024.

Kenneth T. Sim, Executive Chairman of Astrana Health, exercised stock options and reported changes in his beneficial ownership of company stock.

John Vong, Chief Accounting Officer of Astrana Health, Inc., reported a transaction involving the surrender of 636 shares to cover tax obligations related to vesting restricted stock.

Dinesh M. Kumar, Chief Medical Officer of Astrana Health Enablement of Nevada, reports the acquisition of 67,238 shares of restricted common stock and holdings of 216,839 shares.

Chandan Basho, COO and CFO of Astrana Health, Inc., reports the acquisition of restricted stock units and the surrender of shares for tax obligations.